Company: ARAI
Filing Date: 2025-05-13
Form Type: S-1/A
Source: 0001641172-25-009841
Chunk: 65

Company: Arrive AI Inc.
Filing Date: 2025-05-13
Form: S-1/A
Chunk 65
---
 of the future performance of the industries in which we operate that are inherently subject to a high degree of uncertainty and actual events or circumstances may differ materially from events and circumstances reflected in this information. We caution you not to give undue weight to such projections, assumptions and estimates. While we believe that these publications, studies and surveys are reliable, we have not independently verified the data contained in them. In addition, while we believe that the results and estimates from our internal research are reliable, such results and estimates have not been verified by any independent source.

| 26 |

<div align='center'>USE OF PROCEEDS</div>

The Registered Stockholders may, or may not, elect to sell shares of our common stock covered by this prospectus. To the extent any Registered Stockholder chooses to sell shares of our common stock covered by this prospectus, we will not receive any proceeds from any such sales of our common stock.

<div align='center'>DIVIDEND POLICY</div>

Since our inception, we have not paid any dividends on our common stock, and we currently expect that, for the foreseeable future, all earnings, if any, will be retained for use in the development and operation of our business. In the future, our board of directors may decide, at its discretion, whether dividends may be declared and paid to holders of our common stock.

<div align='center'>CAPITALIZATION</div>

The following table sets forth our cash and cash equivalents and capitalization as of December 31, 2024 (after giving effect to the Reverse Stock Split retrospectively for all periods presented).

This table should be read in conjunction with, and is qualified in its entirety by, reference to “ Summary Historical Financial and Other Data,” “ Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes appearing elsewhere in this prospectus.

|                                                                                       |     | As of             
 December 31, 2024 |             |   |
|:--------------------------------------------------------------------------------------|:----|:------------------|------------:|:--|
| Cash and cash equivalents                                                             |     | $                 |     129,318 |   |
| Stockholders’ equity:                                                                 |     |                   |             |   |
| Common stock, par value $0.0002 per share (after giving effect to the Reverse         
 Stock Split), 200,000,000 shares authorized; 29,120,905 shares issued and outstanding |     |                   |       5,822 |   |
| Additional paid